Jeremy le Brun

Jeremy Le Brun has extensive experience in the pharmaceutical industry, currently serving as a Key Account Manager at Recordati Rare Diseases Inc. since January 2020. Previously, Jeremy held positions including International Brand Manager and Key Account Manager at Sobi from 2011 to 2020, where significant sales growth was achieved for various products. Prior roles include Divisional Sales Executive at Napp, where Jeremy focused on secondary care, formulary approval, and team training. Notable accomplishments include driving substantial sales increases for Butrans, Oxycontin, and Oxynorm. Jeremy's educational background includes a BA (Hons) in Business Studies from Staffordshire University, complemented by A Levels from Wellington School.